Silva Pharmaceuticals Statistics

Total Valuation

DSE:SILVAPHL has a market cap or net worth of BDT 1.35 billion. The enterprise value is 1.27 billion.

Market Cap	1.35B
Enterprise Value	1.27B

Important Dates

The last earnings date was Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	Dec 2, 2024

Share Statistics

DSE:SILVAPHL has 136.50 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	136.50M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	30.52%
Owned by Institutions (%)	n/a
Float	66.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.71
PB Ratio	0.62
P/TBV Ratio	0.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-11.80
EV / Sales	2.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-35.46

Financial Position

The company has a current ratio of 10.37, with a Debt / Equity ratio of 0.02.

Current Ratio	10.37
Quick Ratio	4.35
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-1.44
Interest Coverage	-17.24

Financial Efficiency

Return on equity (ROE) is -4.78% and return on invested capital (ROIC) is -2.44%.

Return on Equity (ROE)	-4.78%
Return on Assets (ROA)	-2.32%
Return on Invested Capital (ROIC)	-2.44%
Return on Capital Employed (ROCE)	-3.95%
Revenue Per Employee	836,122
Profits Per Employee	-180,041
Employee Count	596
Asset Turnover	0.21
Inventory Turnover	0.78

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.19% in the last 52 weeks. The beta is 0.03, so DSE:SILVAPHL's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	-49.19%
50-Day Moving Average	9.94
200-Day Moving Average	13.07
Relative Strength Index (RSI)	55.65
Average Volume (20 Days)	159,673

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:SILVAPHL had revenue of BDT 498.33 million and -107.30 million in losses. Loss per share was -0.79.

Revenue	498.33M
Gross Profit	133.33M
Operating Income	-89.61M
Pretax Income	-88.90M
Net Income	-107.30M
EBITDA	-30.77M
EBIT	-89.61M
Loss Per Share	-0.79

Full Income Statement

Balance Sheet

The company has 136.94 million in cash and 51.55 million in debt, giving a net cash position of 85.39 million or 0.63 per share.

Cash & Cash Equivalents	136.94M
Total Debt	51.55M
Net Cash	85.39M
Net Cash Per Share	0.63
Equity (Book Value)	2.19B
Book Value Per Share	16.02
Working Capital	821.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.09 million and capital expenditures -31.62 million, giving a free cash flow of -35.70 million.

Operating Cash Flow	-4.09M
Capital Expenditures	-31.62M
Free Cash Flow	-35.70M
FCF Per Share	-0.26

Full Cash Flow Statement

Margins

Gross margin is 26.76%, with operating and profit margins of -17.98% and -21.53%.

Gross Margin	26.76%
Operating Margin	-17.98%
Pretax Margin	-17.84%
Profit Margin	-21.53%
EBITDA Margin	-6.17%
EBIT Margin	-17.98%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 1.04%.

Dividend Per Share	0.10
Dividend Yield	1.04%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	1.04%
Earnings Yield	-7.94%
FCF Yield	-2.64%

Dividend Details

Stock Splits

The last stock split was on November 7, 2019. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 7, 2019
Split Type	Forward
Split Ratio	1.05

Scores

DSE:SILVAPHL has an Altman Z-Score of 8.06.

Altman Z-Score	8.06
Piotroski F-Score	n/a